You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

CD105

Showing 26 - 50 of 1,400
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Retinitis Pigmentosa, Stem Cell Transplant Trial in Istanbul (Stem cell implantation)

Completed
  • Retinitis Pigmentosa
  • Stem Cell Transplant
  • Stem cell implantation
  • Istanbul, Turkey
    Acıbadem University
Jan 25, 2023

HIV Trial in Lima (Atripla or Stribild)

Completed
Has Results
  • HIV
  • Atripla or Stribild
  • Lima, Peru
    Asociación Civil Impacta Salud y Educación
Sep 16, 2022

B-Cell Acute Lymphoblastic Leukemia, Adult, B-cell Lymphoma Refractory, B-cell Lymphoma Recurrent Trial in Maywood (Fludarabine,

Active, not recruiting
  • B-Cell Acute Lymphoblastic Leukemia, Adult
  • +2 more
  • Maywood, Illinois
    Loyola University
Aug 11, 2022

Systemic Lupus Erythematosus Trial (CD19 CAR-T cell infusion)

Not yet recruiting
  • Systemic Lupus Erythematosus
  • CD19 CAR-T cell infusion
  • (no location specified)
Oct 24, 2023

Herpes Zoster Trial in Xinxiang (Low Dose Recombinant Herpes Zoster Vaccine (CHO cells), High Dose Recombinant Herpes Zoster

Active, not recruiting
  • Herpes Zoster
  • Low Dose Recombinant Herpes Zoster Vaccine (CHO cells)
  • +5 more
  • Xinxiang, Henan, China
    Yanjin District Center for Disease Control and Prevention
Feb 1, 2023

COVID Trial in Lynwood (BM-Allo.MSC, Placebo)

Active, not recruiting
  • COVID
  • BM-Allo.MSC
  • Placebo
  • Lynwood, California
    St. Francis Medical Center
Jan 31, 2022

Venous Insufficiency of Leg, Venous Insufficiency (Chronic)(Peripheral), Endothelial Dysfunction Trial in Moscow (Endovenous

Completed
  • Venous Insufficiency of Leg
  • +2 more
  • Endovenous laser ablation of great saphenous vein (GSV) and microphlebectomy of varicose veins
  • Pharmacotherapy
  • Moscow, Russian Federation
    N.I. Pirogov National Medical and Surgical Center
Sep 3, 2021

Systemic Lupus Erythematosus Trial (CD19 Universal CAR-?d T Cells)

Not yet recruiting
  • Systemic Lupus Erythematosus
  • CD19 Universal CAR-γδ T Cells
  • (no location specified)
Oct 24, 2023

Metastatic Head and Neck Squamous Cell Carcinoma, Metastatic Squamous Cell Carcinoma of the Hypopharynx, Metastatic Squamous

Active, not recruiting
  • Metastatic Head and Neck Squamous Cell Carcinoma
  • +9 more
  • Houston, Texas
    M D Anderson Cancer Center
Apr 27, 2022

Xerostomia Trial (Mesenchymal stem cell, Isotonic NaCl)

Completed
Has Results
  • Xerostomia
  • Mesenchymal stem cell
  • Isotonic NaCl
  • (no location specified)
Nov 24, 2022

Acute Lymphoblastic Leukemia, in Relapse, Acute Lymphoblastic Leukemia Refractory, B-cell Lymphoma Recurrent Trial in São Paulo

Not yet recruiting
  • Acute Lymphoblastic Leukemia, in Relapse
  • +5 more
  • São Paulo, Brazil
    Hospital Israelita Albert Einstein
Jan 20, 2023

CD160 Expression in Corneal Vessels

Not yet recruiting
  • Corneal Graft Rejection
  • +3 more
  • Immunohistochemistry and clinical analyses on patients and corneas
  • Reims, France
    Damien JOLLY
Aug 11, 2021

Lymphoid Leukemia, Acute, Myeloid Malignancy, Plasma Cell Tumor Trial in Miami (T-cell Receptor a/ß Depleted Donor Lymphocyte

Recruiting
  • Lymphoid Leukemia, Acute
  • +2 more
  • T-cell Receptor α/β Depleted Donor Lymphocyte Infusions
  • Miami, Florida
    Miami Cancer Institute at Baptist Health, Inc
May 24, 2022

Tissue Biopsy and Imaging Studies in HIV-Infected Patients

Recruiting
  • HIV
  • +2 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 20, 2023

    Sepsis, Septic Shock Trial in Kayseri (Mesenchymal stem cells)

    Completed
    • Sepsis
    • Septic Shock
    • Mesenchymal stem cells
    • Kayseri, Turkey
      Erciyes University
    Mar 11, 2022

    Craniofacial Microsomia Trial in São Paulo (Fat grafts supplemented with ADRC, Structural fat grafting)

    Completed
    • Craniofacial Microsomia
    • Fat grafts supplemented with ADRC
    • Structural fat grafting
    • São Paulo, SP, Brazil
      Hospital Municipal Infantil Menino Jesus
    Oct 15, 2021

    Platinum-resistant Ovarian Cancer, Fallopian Tube Cancer, Epithelial Ovarian Cancer Trial (Pegylated Liposomal Doxorubicin +

    Not yet recruiting
    • Platinum-resistant Ovarian Cancer
    • +6 more
    • Pegylated Liposomal Doxorubicin + SL-172154
    • Mirvetuximab + SL-172154
    • (no location specified)
    Jul 29, 2022

    T Cell Lymphoma, T-cell Leukemia Trial in Beijing (chimeric antigen receptor T cell treatment)

    Recruiting
    • T Cell Lymphoma
    • T-cell Leukemia
    • chimeric antigen receptor T cell treatment
    • Beijing, Beijing, China
      Beijing Boren Hospital
    Aug 12, 2022

    Hairy Cell Leukemia, Hairy Cell Leukemia Variant Trial run by the NCI (CD22CART cell infusion)

    Recruiting
    • Hairy Cell Leukemia
    • Hairy Cell Leukemia Variant
    • CD22CART cell infusion
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 25, 2023

    Breast Tumors Trial in Barcelona (Cyclophosphamide, Trastuzumab, Pertuzumab)

    Recruiting
    • Breast Neoplasms
    • Barcelona, Spain
    • +1 more
    May 31, 2022

    Intestinal Disease Trial in Orange (Neostigmine Injectable Solution, Sugammadex injection)

    Not yet recruiting
    • Intestinal Disease
    • Neostigmine Injectable Solution
    • Sugammadex injection
    • Orange, California
      UC Irvine Medical Center
    Oct 31, 2023

    Advanced Malignancies Trial in Beijing (BR105 injection)

    Not yet recruiting
    • Advanced Malignancies
    • BR105 injection
    • Beijing, Beijing, China
      Beijing Cancer Hospital
    Apr 24, 2022

    Hodgkin Lymphoma Trial in Valhalla (Brentuximab Vedotin, Allogeneic Stem Cell Transplantation, Reduced Intensity Conditioning)

    Active, not recruiting
    • Hodgkin Lymphoma
    • Brentuximab Vedotin
    • +2 more
    • Valhalla, New York
      New York Medical College
    Oct 24, 2022

    Antibody-mediated Rejection Trial in Vienna, Berlin (Felzartamab, Placebo)

    Recruiting
    • Antibody-mediated Rejection
    • Vienna, Austria
    • +1 more
    Aug 23, 2022

    Herpes Zoster Trial in Xinxiang (Low dose Recombinant Herpes Zoster Vaccine (CHO cells), High dose Recombinant Herpes Zoster

    Not yet recruiting
    • Herpes Zoster
    • Low dose Recombinant Herpes Zoster Vaccine (CHO cells)
    • +3 more
    • Xinxiang, Henan, China
      Yanjin Center for Disease Control and Prevention
    May 4, 2023